Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concordance Study of Her2 Expression Level in Breast Cancer Tissues

NCT02654444 is registered in ClinicalTrials.gov with Applied Spectral Imaging Ltd. as lead sponsor.

NCT NCT02654444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concordance Study of Her2 Expression Level in Breast Cancer Tissues
Lead sponsor
Applied Spectral Imaging Ltd.
Phase
Observational
Overall status
Completed
Start date
May 31, 2013
Completion date
January 31, 2015
Enrollment
3 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer